SCHEMBL20054433

SCHEMBL20054433

NCc1nc2ccc(-c3ccc(-c4ccc5nc(CN)[nH]c5c4)cc3)cc2[nH]1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AAK1 Q2M2I8 2/20 0.52
CACNA1H O95180 1/20 0.51
RAD52 P43351 1/20 0.50
UBE2N P61088 1/20 0.50
IDO1 P14902 1/20 0.50
MAPT P10636 3/20 0.47
KMT2A Q03164 3/20 0.47
PKM P14618 2/20 0.47
TDP1 Q9NUW8 2/20 0.47
KDM4E B2RXH2 2/20 0.47
MEN1 O00255 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
POLB P06746 1/20 0.46
TPSAB1 Q15661 3/20 0.45
PRSS1 P07477 2/20 0.45
F2 P00734 1/20 0.45
F10 P00742 1/20 0.45
PLG P00747 1/20 0.45
PLAU P00749 1/20 0.45
PRSS2 P07478 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20054529 0.87 AAK1 (0.46) AAK1CACNA1HRAD52UBE2NIDO1
SCHEMBL20054554 0.87 AAK1 (0.46) AAK1CACNA1HRAD52UBE2NIDO1
SCHEMBL20054430 0.81 AAK1 (0.41) AAK1CACNA1HRAD52UBE2NIDO1
SCHEMBL4354084 0.80 TDP1 (0.70) CACNA1HRAD52UBE2NIDO1MAPT
SCHEMBL19377986 0.80 HDAC3 (0.52) CACNA1HRAD52UBE2NIDO1MAPT
SCHEMBL29409142 0.80 TDP1 (0.70) CACNA1HRAD52UBE2NIDO1MAPT
SCHEMBL38661663 0.80 IDO1 (0.76) CACNA1HRAD52UBE2NIDO1MAPT
SCHEMBL31733885 0.80 CACNA1H (0.46) CACNA1HMAPTKDM4EPOLB
Hydrochloric Acid SCHEMBL23705615 0.79 HDAC3 (0.51) CACNA1HRAD52UBE2NIDO1MAPT
Hydrochloric Acid SCHEMBL5204720 0.79 TDP1 (0.68) CACNA1HRAD52UBE2NIDO1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3019196-B1 COMBINATIONS OF HEPATITIS C VIRUS INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2018-06-06 EP disclosed
EP-2802326-B1 HEPATITIS C VIRUS INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2018-04-18 EP disclosed